Søren Ventegodt
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Søren Ventegodt has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
Joav Merrick
Ministry of Social Affairs and Social Services
114 shared publicationsNiels Jørgen Andersen
25 shared publicationsIsack Kandel
21 shared publicationsMohammed Morad
Division of Community Health, Ben Gurion University, Beer-Sheva, Israel
18 shared publicationsNiels Jorgen Andersen
Norwegian School of Management, Sandvika, Norway
16 shared publications- Joav Merrick
National Institute of Child Health and Human Development, Division for Mental Retardation Ministry of Social Affairs and Social Services
15 shared publications
Latest Publications
- 1 January 2023
- Published by Springer Nature
- p. 1251-1256
Complementary and Alternative Medicine (CAM)
- 1 January 2023
- Published by Springer Nature
- p. 853-857
Childhood Diseases and Disabilities
- Open Access
- 3 August 2017
- Published by MedCrave Group Kft. in International Journal of Complementary and Alternative Medicine
- Vol. 8 (3) , 1-7
The Thousand-Year-Old Shamanistic Tradition of Healing Touch in the Northeast Australian Rain Forrest
We have interviewed a shaman, Harold "Mooks" Tayley, who claims to be a shaman in the original traditional line of the rain forest shamans, and we have observed the healing ritual. The traditional shamans of the North East Australian rain forest where aboriginals have been living for thousands of years are using touch and talk for healing. They enter a state of trance that allows them to see the blocked and disturbed body-energy (information) and they are able to manipulate the blockages and free the body and mind from the energetic causes of diseases. The existence of remaining healer-shaman in the ancient line of the rainforest aboriginal medicine men calls for thorough scientific exploration and documentation of the way different people and diseases are treated, and for documenting of the affectivity of the shamanistic treatment. We encourage the Australian authorities to fund research in aboriginal shamanistic healing, as this might be a way to support the Australian indigenous cultures, and preserve inherited tradition and wisdom of the tribes which are very close to getting lost forever. The acknowledgment of a living, healing tradition might also help improving the respect and understanding for the ingenious people, who lack written traditions. A deep, scientific analysis of their healing art might also help understanding the spiritual dimensions of ancient and new aboriginal art, much of which is about spiritual growth and healing.
- 3 August 2017
- Published by MedCrave Group Kft. in International Journal of Complementary and Alternative Medicine
- Vol. 8 (3) , 1-7
Open AccessThe Thousand-Year-Old Shamanistic Tradition of Healing Touch in the Northeast Australian Rain Forrest
We have interviewed a shaman, Harold "Mooks" Tayley, who claims to be a shaman in the original traditional line of the rain forest shamans, and we have observed the healing ritual. The traditional shamans of the North East Australian rain forest where aboriginals have been living for thousands of years are using touch and talk for healing. They enter a state of trance that allows them to see the blocked and disturbed body-energy (information) and they are able to manipulate the blockages and free the body and mind from the energetic causes of diseases. The existence of remaining healer-shaman in the ancient line of the rainforest aboriginal medicine men calls for thorough scientific exploration and documentation of the way different people and diseases are treated, and for documenting of the affectivity of the shamanistic treatment. We encourage the Australian authorities to fund research in aboriginal shamanistic healing, as this might be a way to support the Australian indigenous cultures, and preserve inherited tradition and wisdom of the tribes which are very close to getting lost forever. The acknowledgment of a living, healing tradition might also help improving the respect and understanding for the ingenious people, who lack written traditions. A deep, scientific analysis of their healing art might also help understanding the spiritual dimensions of ancient and new aboriginal art, much of which is about spiritual growth and healing.
- Open Access
- 16 October 2015
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 3, 236
The Use of Nipple Shields: A Review
Introduction: A nipple shield is a breastfeeding aid with a nipple-shaped shield that is positioned over the nipple and areola prior to nursing. Nipple shields are usually recommended to mothers with flat nipples or in cases in which there is a failure of the baby to effectively latch onto the breast within the first 2 days postpartum. The use of nipple shields is a controversial topic in the field of lactation. Its use has been an issue in the clinical literature since some older studies discovered reduced breast milk transfer when using nipple shields, while more recent studies reported successful breastfeeding outcomes. The purpose of this review was to examine the evidence and outcomes associated with nipple shield use. Methods: A literature search was conducted in Ovid MEDLINE, OLDMEDLINE, EMBASE Classic, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL. The primary endpoint was any breastfeeding outcome following nipple shield use. Secondary endpoints included the reasons for nipple shield use and the average/median length of use. For the analysis, we examined the effect of nipple shield use on physiological responses, premature infants, mothers’ experiences, and health professionals’ experiences. Results: The literature search yielded 261 articles, 14 of which were included in this review. Of these 14 articles, three reported on physiological responses, two reported on premature infants, eight reported on mothers’ experiences, and one reported on health professionals’ experiences. Conclusion: Through examining the use of nipple shields, further insight is provided on the advantages and disadvantages of this practice, thus allowing clinicians and researchers to address improvements on areas that will benefit mothers and infants the most.
- 16 October 2015
- Published by Frontiers Media SA in Frontiers in Public Health
- Vol. 3, 236
Open AccessThe Use of Nipple Shields: A Review
Introduction: A nipple shield is a breastfeeding aid with a nipple-shaped shield that is positioned over the nipple and areola prior to nursing. Nipple shields are usually recommended to mothers with flat nipples or in cases in which there is a failure of the baby to effectively latch onto the breast within the first 2 days postpartum. The use of nipple shields is a controversial topic in the field of lactation. Its use has been an issue in the clinical literature since some older studies discovered reduced breast milk transfer when using nipple shields, while more recent studies reported successful breastfeeding outcomes. The purpose of this review was to examine the evidence and outcomes associated with nipple shield use. Methods: A literature search was conducted in Ovid MEDLINE, OLDMEDLINE, EMBASE Classic, EMBASE, Cochrane Central Register of Controlled Trials, and CINAHL. The primary endpoint was any breastfeeding outcome following nipple shield use. Secondary endpoints included the reasons for nipple shield use and the average/median length of use. For the analysis, we examined the effect of nipple shield use on physiological responses, premature infants, mothers’ experiences, and health professionals’ experiences. Results: The literature search yielded 261 articles, 14 of which were included in this review. Of these 14 articles, three reported on physiological responses, two reported on premature infants, eight reported on mothers’ experiences, and one reported on health professionals’ experiences. Conclusion: Through examining the use of nipple shields, further insight is provided on the advantages and disadvantages of this practice, thus allowing clinicians and researchers to address improvements on areas that will benefit mothers and infants the most.
- Open Access
- 9 February 2015
- Published by Avens Publishing Group in Journal of Integrative Medicine & Therapy
- Vol. 2 (1)
Why the Corruption of the World Health Organization (WHO) is the Biggest Threat to the World’s Public Health of Our Time
- 9 February 2015
- Published by Avens Publishing Group in Journal of Integrative Medicine & Therapy
- Vol. 2 (1)
Open AccessWhy the Corruption of the World Health Organization (WHO) is the Biggest Threat to the World’s Public Health of Our Time
- 1 January 2014
- Published by Springer Nature
- p. 1137-1142
Complementary and Alternative Medicine (CAM)
- 1 January 2014
- Published by Springer Nature
- p. 768-772
Childhood Diseases and Disabilities
- 15 February 2012
- Published by Walter de Gruyter GmbH in International Journal of Adolescent Medicine and Health
- Vol. 24 (2) , 97-98
Dean Ornish should receive the Nobel prize in medicine
- 15 February 2012
- Published by Walter de Gruyter GmbH in International Journal of Adolescent Medicine and Health
- Vol. 24 (2) , 97-98
Dean Ornish should receive the Nobel prize in medicine
- 4 November 2011
- Published by Walter de Gruyter GmbH in International Journal of Adolescent Medicine and Health
- Vol. 24 (2) , 113-119
The need for evidence-based, non-drug medicine
Evidence-based medicine (EBM) is defined as “the integration of best research evidence with clinical expertise and patient values.” EBM is based on three equally important key factors: i) the best available scientific evidence; ii) the physician’s experience and intuition; and, iii) the preferences and values of the patient. EBM uses a hierarchy of evidence and critical appraisal of the sources, which makes it possible to balance high quality evidence with documented effectiveness. A treatment that is more safe and effective, but less well documented may very well be the treatment of choice. Ethics (not putting the patient at risk of harm with a treatment if this can be avoided at all) is an important part of EBM. Many pharmaceutical drugs have a number needed to treat (NNT) of approximately 20 [NNT=20, confidence interval CI (5–50)] and the number needed to harm is less well understood and documented. The adverse effect profile of pharmacological agents can be more harmful than non-drug medicine. Most EBM-treatments are likely to be non-drug treatments in the future. There are six steps to the practice of EBM: i) the patients and the physician must work together to define the problem; ii) the patients and the physician must explore the patient’s values and preferences; iii) the information about the possible alternative medical interventions must be discussed and critically appraised; iv) the best, relevant evidence must be applied to the patient as a treatment or cure; v) together, the patient and the physician must evaluate how useful the intervention was; and vi) if the intervention did not help sufficiently, the process must begin again. In this review, we explain, in our opinion, how non-drug EBM should be practiced.
- 4 November 2011
- Published by Walter de Gruyter GmbH in International Journal of Adolescent Medicine and Health
- Vol. 24 (2) , 113-119
The need for evidence-based, non-drug medicine
Evidence-based medicine (EBM) is defined as “the integration of best research evidence with clinical expertise and patient values.” EBM is based on three equally important key factors: i) the best available scientific evidence; ii) the physician’s experience and intuition; and, iii) the preferences and values of the patient. EBM uses a hierarchy of evidence and critical appraisal of the sources, which makes it possible to balance high quality evidence with documented effectiveness. A treatment that is more safe and effective, but less well documented may very well be the treatment of choice. Ethics (not putting the patient at risk of harm with a treatment if this can be avoided at all) is an important part of EBM. Many pharmaceutical drugs have a number needed to treat (NNT) of approximately 20 [NNT=20, confidence interval CI (5–50)] and the number needed to harm is less well understood and documented. The adverse effect profile of pharmacological agents can be more harmful than non-drug medicine. Most EBM-treatments are likely to be non-drug treatments in the future. There are six steps to the practice of EBM: i) the patients and the physician must work together to define the problem; ii) the patients and the physician must explore the patient’s values and preferences; iii) the information about the possible alternative medical interventions must be discussed and critically appraised; iv) the best, relevant evidence must be applied to the patient as a treatment or cure; v) together, the patient and the physician must evaluate how useful the intervention was; and vi) if the intervention did not help sufficiently, the process must begin again. In this review, we explain, in our opinion, how non-drug EBM should be practiced.